Creo Medical released a trading update for the year ending Dec-19, announcing trading in-line with expectations and confirming the year saw the company generate its first commercial Speedboat revenues. More significantly, Creo indicated excellent regulatory progress, continued the roll out of its Clinical Education Programme and initiated third-party manufacturing to meet the demand the company expects to see during 2020E. With an expectation of more trained users, regulatory approvals and incre ....
30 Jan 2020
Cenkos: Creo Medical Group Plc -- Foundations for energising 2020
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Creo Medical Group Plc -- Foundations for energising 2020
Creo Medical Group Plc (CREO:LON) | 34.8 0.1 0.7% | Mkt Cap: 125.6m
- Published:
30 Jan 2020 -
Author:
Chris Donnellan -
Pages:
5
Creo Medical released a trading update for the year ending Dec-19, announcing trading in-line with expectations and confirming the year saw the company generate its first commercial Speedboat revenues. More significantly, Creo indicated excellent regulatory progress, continued the roll out of its Clinical Education Programme and initiated third-party manufacturing to meet the demand the company expects to see during 2020E. With an expectation of more trained users, regulatory approvals and incre ....